S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55

Aspen Pharmacare Stock Forecast, Price & News

-0.36 (-2.46%)
(As of 01/18/2022 02:09 PM ET)
Today's Range
50-Day Range
52-Week Range
334 shs
Average Volume
554 shs
Market Capitalization
$6.46 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive APNHY News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter.

Aspen Pharmacare logo

About Aspen Pharmacare

Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments:^Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment relates to the manufacture and sale of active pharmaceutical ingredient and finished dose form products to third-party customers. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.


See More Headlines

Industry, Sector and Symbol

Private households
Current Symbol
Previous Symbol
Year Founded

Sales & Book Value

Annual Sales
$2.46 billion
Cash Flow
$0.95 per share
Book Value
$9.37 per share


Pretax Margin




Free Float
Market Cap
$6.46 billion
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

1.37 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Aspen Pharmacare (OTCMKTS:APNHY) Frequently Asked Questions

Is Aspen Pharmacare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aspen Pharmacare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Aspen Pharmacare stock.
View analyst ratings for Aspen Pharmacare
or view top-rated stocks.

How has Aspen Pharmacare's stock been impacted by Coronavirus (COVID-19)?

Aspen Pharmacare's stock was trading at $6.75 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, APNHY shares have increased by 109.8% and is now trading at $14.1630.
View which stocks have been most impacted by COVID-19

Are investors shorting Aspen Pharmacare?

Aspen Pharmacare saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 700 shares, an increase of 600.0% from the November 30th total of 100 shares. Based on an average trading volume of 1,600 shares, the days-to-cover ratio is currently 0.4 days.
View Aspen Pharmacare's Short Interest

How often does Aspen Pharmacare pay dividends? What is the dividend yield for Aspen Pharmacare?

Aspen Pharmacare declared an annual dividend on Tuesday, September 7th. Stockholders of record on Thursday, September 23rd will be paid a dividend of $0.129 per share on Tuesday, October 12th. This represents a yield of 0.93%. The ex-dividend date of this dividend is Wednesday, September 22nd.
View Aspen Pharmacare's dividend history

Is Aspen Pharmacare a good dividend stock?

Aspen Pharmacare pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.83%.
View Aspen Pharmacare's dividend history.

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the following people:
  • Stephen Bradley Saad, Group Chief Executive Officer & Executive Director
  • Lorraine Angela Hill, Group Operating Officer
  • Sean Matthew Capazorio, Group Finance Officer
  • Michael Guy Attridge, Finance Director & Executive Director
  • Trevor Ziman, Chief Executive Officer-Asia Pacific

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the OTCMKTS under the ticker symbol "APNHY."

How do I buy shares of Aspen Pharmacare?

Shares of APNHY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspen Pharmacare's stock price today?

One share of APNHY stock can currently be purchased for approximately $14.16.

How much money does Aspen Pharmacare make?

Aspen Pharmacare has a market capitalization of $6.46 billion and generates $2.46 billion in revenue each year.

How many employees does Aspen Pharmacare have?

Aspen Pharmacare employs 9,868 workers across the globe.

What is Aspen Pharmacare's official website?

The official website for Aspen Pharmacare is www.aspenpharma.com.

Where are Aspen Pharmacare's headquarters?

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban T3, 4051. The company can be reached via phone at (731) 580-8600 or via fax at 27-11-239-6144.

This page was last updated on 1/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.